Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.15 USD | +4.45% |
|
+4.28% | +44.51% |
Jun. 24 | Avalo Therapeutics Names Chief Legal Officer | MT |
Jun. 24 | Avalo Therapeutics, Inc. Appoints Paul Varki as Chief Legal Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.51% | 13.6M | |
+17.09% | 44.63B | |
+45.09% | 40.46B | |
-9.70% | 38.07B | |
+33.28% | 32.27B | |
-8.98% | 27.3B | |
+13.37% | 26.53B | |
+44.11% | 14.06B | |
+32.33% | 12.54B | |
-7.26% | 11.28B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Oppenheimer Adjusts Avalo Therapeutics PT to $5 From $7, Maintains Outperform Rating